title: Renal artery occlusion model in dogs for the evaluation of thrombolytic agents.
abstract: The purpose of this study was to develop a model of renal artery occlusion and to investigate the effects of various thrombolytic agents on an acute occlusion of the renal artery with respect to ischemic tolerance of renal parenchyma. In order to do this, a thrombosis model in dogs (n = 36) was established and a total of 72 dorsal renal arteries occluded using autologous clot material. For the in vitro preparing of a clot, autologous blood (20 mL) was withdrawn and 100 U thrombin immediately added. Then 1 mL of the clot material was injected into the dorsal branch of the exposed renal artery. The dogs were divided into 8 groups (2 control groups, 6 therapy groups with local and systemic thrombolytic therapy). Thrombolysis was performed using urokinase, single-chain urokinase, and recombinant tissue-plasminogen activator. In all cases the clot preparation technique allowed complete and stable occlusion of the renal arteries. Local and systemic application of the thrombolytic agents, however, resulted in complete recanalization of the clot material in all study groups. Recombinant tissue-plasminogen activator turned out to be the most effective agent in terms of recanalization time. The technique described allowed effective and reproducible artery occlusion for in vivo experimental work to study comparatively thrombolytic agents with respect to fibrin specificity, lytic efficacy, and side effects.
authors.affiliation: Chirurgische Forschung der Universitätsklinik Freiburg, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Haberstroh
authors.forename: G
authors.initials: G
authors.lastname: Wagner
authors.forename: T
authors.initials: T
authors.lastname: Kiefer
authors.forename: U
authors.initials: U
authors.lastname: Blum
authors.forename: B U
authors.initials: BU
authors.lastname: von Specht
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D004285:Dogs; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D008297:Male; D012078:Renal Artery Obstruction / Q000188:drug therapy*
chemical_list: D005343:Fibrinolytic Agents